title: [Structural and functional features of Epstein-Barr virus LMP-1 gene in patients with anaplastic carcinoma of the nasopharynx in Russia].
abstract: Epstein-Barr virus (EBV) is known to be closely associated with the development of anaplastic nasopharyngeal carcinoma (NPC) in some malignancy endemic regions in South-East Asia. LMP1 gene is one of the EBV latent genes, which encodes a latent membrane protein. LMP1 gene is thought to be a classical oncogene since it morphologically transforms cells in vitro and induces tumors in experimental animals in vivo. LMP1 is one of a few genes which is expressed in NPC tissues. It was first shown that C-terminus of LMP1 gene obtained from NPC patients in South-East Asia contained a deletion of 30 base pairs (bp). However, this deleted LMP1 gene was then found in the EBV isolates persisting among healthy virus carriers and patients with other EBV-associated abnormalities from both NPC endemic and non-endemic regions. The aim of this investigation was to accomplish a molecular biological analysis of EBV LMP1 genes obtained from Russian NPC patients. To this end, the authors isolated and sequenced the LMP1 clones amplified from the tumor tissues from 7 NPC patients at the N. N. Blokhin Russian Cancer Research Center and primary blood lymphocytes (PBL) from 6 healthy donors. As a result, the authors could not find the deletion of the above-mentioned 30 bp in NPC LMP1 clones, but could in one healthy donor (PBL-2). A functional analysis revealed no significant differences between LMP1 variants with or without 30 bp deletion in their capacity to activate NF kappa B and jun/AP-1 transcription factors. Nevertheless, Russian NPC-derived LMP1 variants as compared with those from PBLs featured some specific amino acid exchanges. These data indicate that the 30 bp deletion of LMP1 gene is not a factor that predisposes to NPC in Russia.
authors.forename: V E
authors.initials: VE
authors.lastname: Gurtsevich
authors.forename: L N
authors.initials: LN
authors.lastname: Shcherbak
authors.forename: E V
authors.initials: EV
authors.lastname: Novikova
authors.forename: P
authors.initials: P
authors.lastname: Hahn
authors.forename: N V
authors.initials: NV
authors.lastname: Belousova
authors.forename: V V
authors.initials: VV
authors.lastname: Arkhipov
authors.forename: F A
authors.initials: FA
authors.lastname: Grasser
authors.forename: N
authors.initials: N
authors.lastname: Müller-Lantzsch
authors.forename: O A
authors.initials: OA
authors.lastname: Pavlish
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D001483:Base Sequence; D002277:Carcinoma / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology / Q000821:virology*; D002352:Carrier Proteins / Q000235:genetics*; D003598:Cytoskeletal Proteins; D020031:Epstein-Barr Virus Infections / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology / Q000821:virology*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D047908:Intracellular Signaling Peptides and Proteins; D060588:LIM Domain Proteins; D008297:Male; D008969:Molecular Sequence Data; D009303:Nasopharyngeal Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology / Q000821:virology*; D012426:Russia / Q000453:epidemiology
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D002352:Carrier Proteins; D003598:Cytoskeletal Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D047908:Intracellular Signaling Peptides and Proteins; D060588:LIM Domain Proteins; C484380:PDLIM7 protein, human